Skip to search.
 Dow Up 1.24% Nasdaq Up 0.63%

Abbott Laboratories (ABT)

-NYSE

62.14 Up 0.63(1.02%) 4:02PM EDT|After Hours: 62.14 0.00 (0.00%) 4:58PM EDT

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 38,851,259   35,166,721   30,764,707  
Cost of Revenue15,540,580  14,665,192  13,209,329  
Gross Profit 23,310,679   20,501,529   17,555,378  
Operating Expenses
Research Development4,129,414  3,724,424  2,743,733  
Selling General and Administrative12,756,817  10,376,324  8,405,904  
Non Recurring672,500  313,200  170,000  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 5,751,948   6,087,581   6,235,741  
Income from Continuing Operations
Total Other Income/Expenses Net(23,165)178,388  1,477,689  
Earnings Before Interest And Taxes5,728,783  6,265,969  7,713,430  
Interest Expense530,141  553,135  519,656  
Income Before Tax5,198,642  5,712,834  7,193,774  
Income Tax Expense470,193  1,086,662  1,447,936  
Minority Interest -   -   -  
Net Income From Continuing Ops4,728,449  4,626,172  5,745,838  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 4,728,449   4,626,172   5,745,838  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 4,728,449   4,626,172   5,745,838  

Currency in USD.